Better regulation and transparency

10 December 2015 | StanDerm expresses concerns about EU Commission publication

In response  to an image used by the European Commission in a recent publication on “Better regulation and transparency”, 

StanDerm sent a letter to the European Commissioner for Employment, Social Affairs, Skills and Labour Mobility, Mrs. Marianne Thyssen to convey its support with the concerns expressed by  Coiffure EU and UNI Europa and the European Association of Dermatology and Venereology (EADV)  about this taunting image. The Commission openly mocks the ongoing efforts of social partners to implement a European Framework Agreement on health and safety in the hairdressing sector signed in April 2012, under the presence of the then Commissioner of Employment, Social Affairs and Inclusion Laszlo Andor. WHO and ILO, together with the EADV regarded it a major European breakthrough in safety and health since it is an autonomous initiative on the part of the workers and employers of the hairdressing sector. 




Classification of MCIT/MIT

05 October 2015 | StanDerm submitted statement to the CLH public consultation.


On 26 August, StanDerm submitted a statement to the CLH public consultation related to the proposed classification of MCIT/MIT.  After having considered the report for 2-methylisothiazol-3(2H)-one (MIT), StanDerm postulates that the limits for attributing the H317 risk phrase and for labeling MIT should not be higher than the presently recommended maximum use concentrations for rinse-off cosmetics (see SCCS/1521/13). Based on extensive clinical experience, the proposed threshold concentration of 0.06% is definitely not low enough to protect workers and consumers from skin sensitization.